Frontiers in immunology, 2021-09, Vol.12, p.753319-753319
2021
Details
- Autor(en) / Beteiligte
- Titel
- Heterologous Ad26.COV2.S Prime and mRNA-Based Boost COVID-19 Vaccination Regimens: The SWITCH Trial Protocol
- Ist Teil von
- Frontiers in immunology, 2021-09, Vol.12, p.753319-753319
- Ort / Verlag
- Switzerland: Frontiers Media S.A
- Erscheinungsjahr
- 2021
- Link zum Volltext
- Quelle
- Free E-Journal (出版社公開部分のみ）
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1664-3224eISSN: 1664-3224DOI: 10.3389/fimmu.2021.753319Titel-ID: cdi_doaj_primary_oai_doaj_org_article_21c54a720c2448ea8a74e527222a33ae
- Format
- –
- Schlagworte
- 2019-nCoV Vaccine mRNA-1273, Ad26.Cov2.S, Ad26COVS1, BNT162 Vaccine, COVID-19, COVID-19 - immunology, COVID-19 - prevention & control, COVID-19 Vaccines - administration & dosage, Heterologous vaccine regimen, Homologous vaccination regimen, Humans, Immunization, Secondary, Immunology, randomized clinical trial, SARS-CoV-2